The newly FDA-approved Cefaly headband is the 1st device on the U.S. market indicated for preventive treatment of migraine pain.
FDA regulators today announced landmark approval of a mobile headband-like device indicated for prevention of migraines and migraine pain. The device, called the Cefaly system, is the 1st of its kind and is indicated as an alternative to drug therapy.
News Well, Food & Drug Administration (FDA), Neuromodulation/Neurostimulation, Pre-Market Approval (PMA)
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/N4HPXh
Cap comentari:
Publica un comentari a l'entrada